top of page

The Foot & Ankle Consolidation Trend Continues

  • kshepherd72
  • May 19, 2022
  • 1 min read

On May 4, CONMED Corporation (NYSE: CNMD) announced a definitive agreement to acquire privately-held In2Bones Global, Inc. for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.

In2Bone, led by foot and ankle veteran Alan Taylor, had 2021 revenue of $36.8 million with sustained double-digit growth. While CONMED is a large company, including 3,500 employees, it has a small footprint in foot and ankle, making this a partnership an upside on both sides.

 
 
 

Recent Posts

See All
ASA DEN'AI'LI

Name changes, like the recent reversion of Alaska’s Denali back to its former name,  Mount McKinley , are seen as a current form of power...

 
 
 

Comentarios


FIX Masthead 2000x318 v2.jpg
bottom of page